SIP Hack to Reach Rs 10 Crore Retirement Corpus—One Fund Even Grew to Rs 18.34 Crore Using This Strategy!
SIP Hack to Reach Rs 10 Crore Retirement Corpus—One Fund Even Grew to Rs 18.34 Crore Using This Strategy!

SIP Hack to Reach Rs 10 Crore Retirement Corpus—One Fund Even Grew to Rs 18.34 Crore Using This Strategy!

The short answer: Yes! But only if you know this simple hack.

Karan Dsij Article rating: 3.3

Is it possible for a young professional, aged 29-30, to accumulate a Rs 10 crore retirement corpus by the time they retire, even if they are just starting to invest in mutual funds now?

From Wall Street to Dalal Street, Bears Rule Amid U.S. Consumer Confidence Slump
From Wall Street to Dalal Street, Bears Rule Amid U.S. Consumer Confidence Slump

From Wall Street to Dalal Street, Bears Rule Amid U.S. Consumer Confidence Slump

After plunging 15-16 per cent from its record highs, the Nifty 50 is now approaching the 22,000 level, marked by a significant red candle today. Here's why!

Mandar Wagh Article rating: 5.0

After plunging 15-16 per cent from its record highs, the Nifty 50 is now approaching the 22,000 level, marked by a significant red candle today. Here's why!

 

350 Per Cent Returns: Water Theme Company Reports 33 Per Cent PAT Growth, Sales Up 21 Per Cent
350 Per Cent Returns: Water Theme Company Reports 33 Per Cent PAT Growth, Sales Up 21 Per Cent

350 Per Cent Returns: Water Theme Company Reports 33 Per Cent PAT Growth, Sales Up 21 Per Cent

Net profit witnessed a 33 per cent YoY increase, reaching Rs 73.1 crore, compared to Rs 54.9 crore in Q4 CY23.

Manoj Reddy Sama Article rating: 4.1

Over the last five years, the stock has delivered an impressive return of 352.55 per cent. The company’s current market capitalization stands at Rs 10,603 crore.

Pharma Stocks Under Pressure: Shares Drop Nearly 4 per cent Despite Diabetes and Obesity Drug Launch in UK
Pharma Stocks Under Pressure: Shares Drop Nearly 4 per cent Despite Diabetes and Obesity Drug Launch in UK

Pharma Stocks Under Pressure: Shares Drop Nearly 4 per cent Despite Diabetes and Obesity Drug Launch in UK

With GLP-1 therapies expected to be a significant revenue driver in the future, Biocon aims to strengthen its footprint in this segment.

Abhishek Wani Article rating: 4.3

With GLP-1 therapies expected to be a significant revenue driver in the future, Biocon aims to strengthen its footprint in this segment.

Railway Kavach Company Bags New Order Worth Rs 325,33,00,000 From South Eastern Railway
Railway Kavach Company Bags New Order Worth Rs 325,33,00,000 From South Eastern Railway

Railway Kavach Company Bags New Order Worth Rs 325,33,00,000 From South Eastern Railway

The stock gave multibagger returns of 167 per cent from its 52-week low, 700 per cent in 3 years and a whopping 4,300 per cent in 5 years.

Kiran Shroff Article rating: 3.7

The stock gave multibagger returns of 167 per cent from its 52-week low, 700 per cent in 3 years and a whopping 4,300 per cent in 5 years.

Shares Below Rs 100: Only Buyers Were Seen In These Stocks, Locked in Upper Circuit Today
Shares Below Rs 100: Only Buyers Were Seen In These Stocks, Locked in Upper Circuit Today

Shares Below Rs 100: Only Buyers Were Seen In These Stocks, Locked in Upper Circuit Today

The broader markets were in the red territory, with the BSE Mid-cap Index down 2.26 per cent and the BSE Small-cap Index down 2.33 per cent.

Kiran Shroff Article rating: 3.1

The broader markets were in the red territory, with the BSE Mid-cap Index down 2.26 per cent and the BSE Small-cap Index down 2.33 per cent.

UPI 3.0 – What’s Next for India’s Digital Payments Revolution?
UPI 3.0 – What’s Next for India’s Digital Payments Revolution?

UPI 3.0 – What’s Next for India’s Digital Payments Revolution?

How UPI 3.0 Will Transform Digital Payments with Offline Transactions, Global Reach, and Credit Access

Pushkar Shinde Article rating: 3.9

How UPI 3.0 Will Transform Digital Payments with Offline Transactions, Global Reach, and Credit Access

Small-Cap Pharma Stock Plunges as US Regulatory Letter Wipes Out Rs 938 Crore in Market Cap—But It’s Not All Bad News
Small-Cap Pharma Stock Plunges as US Regulatory Letter Wipes Out Rs 938 Crore in Market Cap—But It’s Not All Bad News

Small-Cap Pharma Stock Plunges as US Regulatory Letter Wipes Out Rs 938 Crore in Market Cap—But It’s Not All Bad News

Despite the sharp decline, the regulatory setback isn't as severe as it seems—the letter only raises compliance concerns without halting operations or triggering an import alert.

Abhishek Wani Article rating: 5.0

Despite the sharp decline, the regulatory setback isn't as severe as it seems—the letter only raises compliance concerns without halting operations or triggering an import alert.

RSS
First1617181921232425Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR